Multiscale biophysics · immune engineering

Immune Design · Molecule to Organoid

One 3D observatory opens three scales at once: receptor–antigen binding on the left, a T cell compressing graded input into a switch-like decision in the center, and effector cells infiltrating and clearing a tumor organoid on the right. Tune the system and expose its real bottleneck.

Molecular occupancy

\theta

$0.90$

Cell activation

A

$0.95$

Organoid cleared

C

$0.0\%$

Clearance rate $0.21\,\mathrm{h}^{-1}$

Limiting scaleCascade open

Assay time $0.0\,\mathrm h$

This is an educational causal model: binding uses effective surface units, the cell uses a cooperative threshold, and tissue outcome uses a mean clearance rate. It explains why failure at one scale defeats upstream optimization; it does not predict patient response or dose.

Physics tutorial

How does one molecule reach a whole tissue?

BackgroundImmune engineering is not three independent problems. A receptor first contacts a target molecule; intracellular networks compress that graded input into an activated or silent decision; only activated effectors that enter tissue and perform serial killing can produce macroscopic clearance.

Why it mattersThis is why making a receptor “stickier” does not guarantee success. Scarce antigen, a strong checkpoint brake, or poor tissue access can each reduce the whole cascade to zero.

Start with the essentials

Focus question: Which scale limits final clearance, and when does improving an upstream molecular design matter—or disappear inside a downstream bottleneck?
One-sentence intuition: Multiscale design optimizes the complete causal product, not an isolated maximum. Molecular occupancy creates the input, a cooperative threshold converts it into a cell decision, and tissue access sets the final clearance rate.

Core mathematical model

Molecular binding gate

\theta=\frac{\rho_A}{\rho_A+K_D^\ast}

Effective surface units represent antigen presentation and half-saturation. More antigen or a lower effective half-saturation raises occupancy. This is an educational mapping, not a claim that membrane binding is a bulk concentration.

Cooperative cell threshold

A=\frac{\left[(1-b)\theta\right]^n}{\left[(1-b)\theta\right]^n+\tau^n}

The checkpoint brake $b$ first attenuates the input; cooperativity $n$ then compresses a smooth molecular change into a steep, almost digital cellular decision.

Tissue clearance

C(t)=1-\exp\!\left[-k_{\max}A\,\frac{R_{E:T}}{R_{E:T}+R_{1/2}}\,t\right]

The organoid layer multiplies activation by effector access to obtain a mean clearance rate. Real tissue also includes migration, exhaustion, spatial barriers, and clonal heterogeneity; this equation keeps only the key serial-system structure.

Common difficulties

Higher affinity is not the same as better therapy

Typical misconceptionIf receptor binding becomes strong enough, the tissue must be cleared.

Better mental modelBinding opens only the first gate. Checkpoints, signaling thresholds, infiltration, and effector abundance remain downstream. If any one closes, upstream gain never reaches the tissue.

This is not a patient digital twin

Typical misconceptionReal assay values entered into the sliders would predict one patient’s response.

Better mental modelThe lab compresses complex processes into a few dimensionless parameters to expose causality and bottlenecks. It is not trained or calibrated to clinical outcomes and cannot guide diagnosis, dose, or treatment.

Run the experiment

01
Create immune escape
Choose Immune escape and identify which of the three worlds dims first.
What to observe: Low antigen and weak binding reduce molecular occupancy first; cell signaling and organoid clearance shut down downstream.
02
Repair only the molecule
Choose Receptor redesign, then gradually raise the checkpoint brake.
What to observe: Binding on the left stays bright, but the center cell decision suddenly switches off at its threshold and tissue clearance disappears with it.
03
Open the complete cascade
Choose Checkpoint rescue, then lower the effector ratio.
What to observe: Molecular and cellular gates remain open, but the bottleneck moves to tissue access. Restoring the effector ratio makes the organoid collapse.